Cheng Har Yip

The paper develops a population-specific gene signature, MyGESig, which improves survival prediction in Malaysian breast cancer patients compared to existing models.

This study evaluates the prognostic value of immune markers in Asian breast cancer using spatial immunophenotyping and multimodal machine learning, finding that integrated spatial and molecular profiling improves prognostication.

This study identifies immune phenotype-driven clustering in HR+/HER2- breast cancer from an Asian cohort, deviating from the luminal A-luminal B classification seen in European populations.